ASHFIELD
ActiveSummary
ASHFIELD has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.3m and a net result of €409,705. Equity is growing by ~15.1% per year across the filed fiscal years. Its solvency ranks better than 56% of 5046 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability47▲+9
Solvency76▲+10
Growth44▲+1
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €150,000 at 30 days acceptable
Liquidity ample (current ratio 2.47 against 0.71 in 2024; short-term debt: 40.1% and cash: 18% of total assets), and 49.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
50.9%
Return on assets
9.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
35 d early
2023
41 d early
2022
35 d early
2021
37 d early
2020
on the day
2019
46 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 16 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
On 4 August 1994, ASHFIELD was incorporated.1 The capital was increased 4 times between 2004 and 2012, most recently to EUR 800,000.234 The name was changed to pharmexx in 2010 and to ASHFIELD in 2014.56 In 2010 the registered office moved to Wavre.7 Benjamin RAPP has served as director of the company since 2021.8 Revenue went from EUR 9.3 million in 2018 to EUR 7.8 million in 2025 and headcount from 114 to 67.4 full-time equivalents.9
- 1Crossroads Bank for Enterprises
- 2Belgian State Gazette, 10-12-2004
- 3Belgian State Gazette, 02-08-2010
- 4Belgian State Gazette, 01-08-2012
- 5Belgian State Gazette, 25-03-2010
- 6Belgian State Gazette, 20-01-2014
- 7Belgian State Gazette, 16-12-2010
- 8Belgian State Gazette, 08-10-2021
- 9National Bank, annual accounts 2018 and 2025
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
€7.8m▼ 2.0%
2024 · €8.0m
EBIT margin
5.2%▲ 2.2pp
2024 · 3.0%
Net result
€409,705▲ 59.3%
2024 · €257,240
Working capital
€2.6m
2024 · -€670,321
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€9.6m▲ 33.3%€8.6m▼ 10.9%€8.9m▲ 3.5%€8.0m▼ 10.1%€7.8m▼ 2.0%
Operating result€203,188€223,089▲ 9.8%€159,818▼ 28.4%€243,179▲ 52.2%€410,595▲ 68.8%
Net result€150,071within the sector's middle half€212,572within the sector's middle half▲ 41.6%€205,406within the sector's middle half▼ 3.4%€257,240within the sector's middle half▲ 25.2%€409,705within the sector's middle half▲ 59.3%
EBIT margin2.1%▲ 5.1pp2.6%▲ 0.5pp1.8%▼ 0.8pp3.0%▲ 1.2pp5.2%▲ 2.2pp
Equity€1.2mwithin the sector's middle half▲ 14.6%€1.4mwithin the sector's middle half▲ 18.0%€1.6mwithin the sector's middle half▲ 14.8%€1.9mwithin the sector's middle half▲ 16.1%€2.3mwithin the sector's middle half▲ 22.1%
Total assets€3.3mwithin the sector's middle half▲ 6.3%€4.4mwithin the sector's middle half▲ 32.3%€4.5mwithin the sector's middle half▲ 4.4%€4.5mwithin the sector's middle half▼ 0.5%€4.5mwithin the sector's middle half▼ 1.5%
Debt€2.1m▲ 8.8%€3.0m▲ 40.3%€2.9m▼ 0.5%€2.7m▼ 9.5%€2.2m▼ 17.9%
Working capital€1.4mwithin the sector's middle half▲ 27.7%€1.8mwithin the sector's middle half▲ 26.3%€2.0mwithin the sector's middle half▲ 9.2%-€670,321below the sector's middle half€2.6mwithin the sector's middle half
Solvency35.9%within the sector's middle half▲ 2.6pp32.0%within the sector's middle half▼ 3.9pp35.2%within the sector's middle half▲ 3.2pp41.0%within the sector's middle half▲ 5.9pp50.9%within the sector's middle half▲ 9.8pp
Current ratio1.80within the sector's middle half▲ 0.191.73within the sector's middle half▼ 0.071.79within the sector's middle half▲ 0.060.71below the sector's middle half▼ 1.082.47within the sector's middle half▲ 1.76
Return on assets (ROA)4.6%within the sector's middle half▲ 13.6pp4.9%within the sector's middle half▲ 0.3pp4.5%within the sector's middle half▼ 0.4pp5.7%within the sector's middle half▲ 1.2pp9.2%above the sector's middle half▲ 3.5pp
Staff (FTE)90.3above the sector's middle half▼ 8.8%74.4above the sector's middle half▼ 17.6%71.8above the sector's middle half▼ 3.5%72.9above the sector's middle half▲ 1.5%67.4above the sector's middle half▼ 7.5%
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 69% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.5m
Fixed assets
€37,476 ▼ 98.7%
Current assets
€4.4m ▲ 171%
Equity and liabilities €4.5m
Equity
€2.3m ▲ 22.1%
Debt
€2.2m ▼ 17.9%
Debt's share of the balance-sheet total falls from 59.0% to 49.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€411,559▲
2024 · €248,298
Cash flow
€410,669▲
2024 · €262,359
Debt to equity
0.97▼
2024 · 1.44
ROE
18.1%▲
2024 · 13.9%
Interest coverage
2.39▲
2024 · 1.86
Debt ≤ 1 year
€1.8m▼
2024 · €2.3m
Income taxes
€13,210▼
2024 · €17,235
Staff costs
€5.2m▲
2024 · €5.1m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,577 companies that looked in July 2024 the way this one looks now, 0.1% went bankrupt within 24 months and 97% are still going.
- Medium-sized
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.1%
went bankrupt
3.1%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,577 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €9.9m | €8.8m | €9.1m | €8.2m | €8.0m | ▼ 2.2% |
| Turnover70 | €9.6m | €8.6m | €8.9m | €8.0m | €7.8m | ▼ 2.0% |
| Other operating income74 | €263,030 | €176,476 | €178,174 | €172,003 | €153,174 | ▼ 10.9% |
| Operating charges60/66A | €9.7m | €8.5m | €8.9m | €7.9m | €7.6m | ▼ 4.4% |
| Services and other goods61 | €2.4m | €2.4m | €2.7m | €2.8m | €2.4m | ▼ 14.9% |
| Remuneration, social security and pensions62 | €7.4m | €6.1m | €6.2m | €5.1m | €5.2m | ▲ 1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €53,537 | €7,993 | €6,461 | €5,119 | €964 | ▼ 81.2% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | -€126,784 | - | - | - | - | - |
| Other operating charges640/8 | €6,770 | €3,499 | €3,340 | - | €369 | - |
| Non-recurring operating charges66A | - | €38,970 | - | - | - | - |
| Operating profit (loss)9901 | €203,188 | €223,089 | €159,818 | €243,179 | €410,595 | ▲ 68.8% |
| Financial income75/76B | €10,212 | €32,996 | €108,617 | €165,034 | €184,625 | ▲ 11.9% |
| Recurring financial income75 | €10,212 | €32,996 | €108,617 | €165,034 | €184,625 | ▲ 11.9% |
| Income from current assets751 | €10,212 | €32,996 | €108,617 | €165,034 | €184,625 | ▲ 11.9% |
| Financial charges65/66B | €40,503 | €27,427 | €46,365 | €133,739 | €172,306 | ▲ 28.8% |
| Recurring financial charges65 | €40,503 | €27,427 | €46,365 | €133,739 | €172,306 | ▲ 28.8% |
| Debt charges650 | €40,019 | €27,427 | €46,365 | €133,685 | €172,306 | ▲ 28.9% |
| Other financial charges652/9 | €484 | - | - | €54 | - | - |
| Profit (loss) for the period before taxes9903 | €172,897 | €228,659 | €222,070 | €274,474 | €422,915 | ▲ 54.1% |
| Income taxes67/77 | €22,827 | €16,087 | €16,664 | €17,235 | €13,210 | ▼ 23.4% |
| Taxes670/3 | €22,827 | €16,087 | €16,664 | €17,235 | €13,210 | ▼ 23.4% |
| Profit (loss) for the period9904 | €150,071 | €212,572 | €205,406 | €257,240 | €409,705 | ▲ 59.3% |
| Profit (loss) for the period to be appropriated9905 | €150,071 | €212,572 | €205,406 | €257,240 | €409,705 | ▲ 59.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €3.3m | €4.4m | €4.5m | €4.5m | €4.5m | ▼ 1.5% |
| Fixed assets21/28 | €30,916 | €29,266 | €22,805 | €2.9m | €37,476 | ▼ 98.7% |
| Tangible fixed assets22/27 | €15,000 | €13,350 | €6,889 | €1,569 | €606 | ▼ 61.4% |
| Furniture and vehicles24 | €15,000 | €13,350 | €6,889 | €1,569 | €606 | ▼ 61.4% |
| Other tangible fixed assets26 | €0 | - | - | - | - | - |
| Financial fixed assets28 | €15,916 | €15,916 | €15,916 | €2.9m | €36,870 | ▼ 98.7% |
| Affiliated companies280/1 | - | - | - | €2.9m | - | - |
| Amounts receivable281 | - | - | - | €2.9m | - | - |
| Other financial fixed assets284/8 | €15,916 | €15,916 | €15,916 | €36,870 | €36,870 | = |
| Shares284 | €100 | €100 | €100 | €100 | €100 | = |
| Amounts receivable and cash guarantees285/8 | €15,816 | €15,816 | €15,816 | €36,770 | €36,770 | = |
| Current assets29/58 | €3.3m | €4.3m | €4.5m | €1.6m | €4.4m | ▲ 171% |
| Amounts receivable within one year40/41 | €2.2m | €3.2m | €4.1m | €1.3m | €3.6m | ▲ 169% |
| Trade receivables40 | €1.3m | €1.7m | €1.2m | €1.3m | €1.0m | ▼ 25.0% |
| Other amounts receivable41 | €826,998 | €1.5m | €2.8m | €6,851 | €2.6m | ▲ 38,020% |
| Cash at bank and in hand54/58 | €1.1m | €1.1m | €462,433 | €285,717 | €800,174 | ▲ 180% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €3.3m | €4.4m | €4.5m | €4.5m | €4.5m | ▼ 1.5% |
| Equity10/15 | €1.2m | €1.4m | €1.6m | €1.9m | €2.3m | ▲ 22.1% |
| Contributions10/11 | €800,000 | €800,000 | €800,000 | €800,000 | €800,000 | = |
| Capital10 | €800,000 | €800,000 | €800,000 | €800,000 | €800,000 | = |
| Issued capital100 | €800,000 | €800,000 | €800,000 | €800,000 | €800,000 | = |
| Reserves13 | €59,711 | €70,339 | €80,000 | €80,000 | €80,000 | = |
| Non-distributable reserves130/1 | €59,711 | €70,339 | €80,000 | €80,000 | €80,000 | = |
| Legal reserve130 | €59,711 | €70,339 | €80,000 | €80,000 | €80,000 | = |
| Profit (loss) carried forward14 | €320,268 | €522,211 | €717,956 | €975,196 | €1.4m | ▲ 42.0% |
| Provisions and deferred taxes16 | €0 | - | - | - | - | - |
| Provisions for liabilities and charges160/5 | €0 | - | - | - | - | - |
| Amounts payable17/49 | €2.1m | €3.0m | €2.9m | €2.7m | €2.2m | ▼ 17.9% |
| Amounts payable within one year42/48 | €1.8m | €2.5m | €2.5m | €2.3m | €1.8m | ▼ 22.4% |
| Trade debts44 | €258,252 | €621,758 | €769,687 | €591,238 | €328,721 | ▼ 44.4% |
| Suppliers440/4 | €258,252 | €620,052 | €760,954 | €576,636 | €300,063 | ▼ 48.0% |
| Bills of exchange payable441 | - | €1,707 | €8,734 | €14,602 | €28,659 | ▲ 96.3% |
| Taxes, remuneration and social security45 | €1.4m | €1.7m | €1.6m | €1.6m | €1.3m | ▼ 16.4% |
| Taxes450/3 | €180,461 | €235,040 | €151,572 | €275,399 | €319,724 | ▲ 16.1% |
| Remuneration and social security454/9 | €1.2m | €1.5m | €1.5m | €1.3m | €1.0m | ▼ 23.2% |
| Other amounts payable47/48 | €154,267 | €131,187 | €114,572 | €108,304 | €119,537 | ▲ 10.4% |
| Accrued charges and deferred income492/3 | €298,558 | €465,099 | €422,104 | €362,923 | €400,925 | ▲ 10.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €150,071 | €212,572 | €205,406 | €257,240 | €409,705 | ▲ 59.3% |
| + Depreciation and write-downs630 | €53,537 | €7,993 | €6,461 | €5,119 | €964 | ▼ 81.2% |
| Operating cash flow (approximation) | €203,608 | €220,565 | €211,867 | €262,359 | €410,669 | ▲ 56.5% |
| Investment in fixed assets (approximation) | - | -€6,343 | €0 | -€2.9m | €2.9m | ▲ 199% |
| Change in cash | - | -€5,627 | -€633,683 | -€176,715 | €514,457 | ▲ 391% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Liquidity triplescurrent ratio 2.47
Current ratio from 0.71 to 2.47; short-term debt falls from €2.3m to €1.8m.
31-12
Financial
Equity above €2mEq €2.3m ▲22.1%
5 profitable years in a row build equity to €2.3m.
26-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
20-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
05-12
State Gazette act
Reappointment: EY Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Christophe Beckers · Approval · Director discharge7 facts ▸
State Gazette act
Reappointment: EY Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Christophe Beckers · Approval · Director discharge7 facts ▸
- General meeting, 21-06-2023
- Approval, jaarrekening, 31-12-2022
- Director discharge, Ashfield Healthcare (bestuurders)
- Director discharge, EY Bedrijfsrevisoren BV (statutory auditor)
- Auditor reappointment, EY Bedrijfsrevisoren BV
- Permanent representative, Christophe Beckers
- Power of attorney, Jean-Paul Blondeel
26-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
24-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Back to profitnet €150,071
Net result €150,071 after one loss-making year.
08-10
State Gazette act
Resignation: Mick O'LEARY (director)Appointment: Benjamin RAPP (director) · Reappointment: EY bedrijfsrevisoren BV (statutory auditor) · Permanent representative: Christophe Beckers11 facts ▸
State Gazette act
Resignation: Mick O'LEARY (director)
Appointment: Benjamin RAPP (director) · Reappointment: EY bedrijfsrevisoren BV (statutory auditor) · Permanent representative: Christophe Beckers11 facts ▸
- General meeting, 28-09-2021
- Statutes amendment
- Statutes amendment
- Statutes amendment
- Statutes amendment
- Capital, €800.000
- Director resignation, Mick O'LEARY (director)
- Director appointment, Benjamin RAPP (director)
- Mandate compensation, Benjamin RAPP
- Auditor reappointment, EY bedrijfsrevisoren BV
- Permanent representative, Christophe Beckers
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
30-09
Financial
Weakest financial yearnet -€280,727
Net result drops to -€280,727, the lowest in the series; recovery starts the following year.
Show earlier events
15-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 46 days late
26-02
State Gazette act
Resignations: Nigel MANSFORD (director) and Julian TOMPKINS (director)Appointments: Mick OLEARY (director) and Jan NOTEBOOM (director)5 facts ▸
State Gazette act
Resignations: Nigel MANSFORD (director) and Julian TOMPKINS (director)
Appointments: Mick OLEARY (director) and Jan NOTEBOOM (director)5 facts ▸
- General meeting, 16-09-2019
- Director resignation, Nigel MANSFORD (director)
- Director resignation, Julian TOMPKINS (director)
- Director appointment, Mick OLEARY (director)
- Director appointment, Jan NOTEBOOM (director)
2019
30-09
Financial
Equity above €1mEq €1.3m ▲33.3%
2 profitable years in a row build equity to €1.3m.
16-04
State Gazette act
Resignation: Nigel Mansford (day-to-day manager)2 facts ▸
State Gazette act
Resignation: Nigel Mansford (day-to-day manager)
2 facts ▸
- Board meeting, 06-03-2019
- Director resignation, Nigel Mansford (day-to-day manager)
10-04
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
25-01
State Gazette act
Resignation: Christophe REYNTJENS (day-to-day manager)Power of attorney · Signing date4 facts ▸
State Gazette act
Resignation: Christophe REYNTJENS (day-to-day manager)
Power of attorney · Signing date4 facts ▸
- Board meeting, 03-09-2018
- Director resignation, Christophe REYNTJENS (day-to-day manager)
- Power of attorney, Jean Paul BLONDEEL
- Signing date, 26-09-2018
2018
20-02
State Gazette act
Resignation: KPMG (statutory auditor)Appointment: Ernst & Young Bedrijfsrevisoren CVBA (statutory auditor) · Director discharge4 facts ▸
State Gazette act
Resignation: KPMG (statutory auditor)
Appointment: Ernst & Young Bedrijfsrevisoren CVBA (statutory auditor) · Director discharge4 facts ▸
- General meeting, 28/02/2017
- Director discharge, KPMG (statutory auditor)
- Director resignation, KPMG (statutory auditor)
- Auditor appointment, Ernst & Young Bedrijfsrevisoren CVBA (statutory auditor)
12-02
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
24-01
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
11-01
State Gazette act
Reappointment: KPMG (statutory auditor)Registered-office move4 facts ▸
State Gazette act
Reappointment: KPMG (statutory auditor)
Registered-office move4 facts ▸
- Board meeting, 04-12-2016
- Registered-office move, Fountain Plaza, Building 501, Belgicastraat 1, 1930 - Zaventem
- General meeting, 18-03-2016
- Auditor reappointment, KPMG
2016
26-07
State Gazette act
Resignation: Clare BATES (director)Appointment: Nigel Mansford (director) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Clare BATES (director)
Appointment: Nigel Mansford (director) · Mandate compensation4 facts ▸
- General meeting, 24-06-2016
- Director resignation, Clare BATES (director)
- Director appointment, Nigel Mansford (director)
- Mandate compensation, Nigel Mansford
2014
24-11
State Gazette act
Permanent representatives: Dominic Rousselle and Sophie BrabantPower of attorney5 facts ▸
State Gazette act
Permanent representatives: Dominic Rousselle and Sophie Brabant
Power of attorney5 facts ▸
- Board meeting, 22-10-2014
- Power of attorney, Christophe REYNTJENS
- Power of attorney, Sylvie HATERT
- Permanent representative, Dominic Rousselle
- Permanent representative, Sophie Brabant (statutory auditor)
20-01
State Gazette act
Resignation: Graham Millan Mcintosh (director)Appointment: Julian Hedley Tompkins (director) · Name change · Mandate compensation5 facts ▸
State Gazette act
Resignation: Graham Millan Mcintosh (director)
Appointment: Julian Hedley Tompkins (director) · Name change · Mandate compensation5 facts ▸
- General meeting, 20-12-2013
- Name change, ASHFIELD
- Director resignation, Graham Millan Mcintosh (director)
- Director appointment, Julian Hedley Tompkins (director)
- Mandate compensation, Julian Hedley Tompkins
2013
06-12
State Gazette act
Resignations: ENHANCED HEALTHCARE MANAGEMENT SPRL (director) and SCRL Ernst & Young Réviseurs d'Entreprises (statutory auditor)Appointment: KPMG Réviseurs d'Entreprises (statutory auditor) · General meeting decision6 facts ▸
State Gazette act
Resignations: ENHANCED HEALTHCARE MANAGEMENT SPRL (director) and SCRL Ernst & Young Réviseurs d'Entreprises (statutory auditor)
Appointment: KPMG Réviseurs d'Entreprises (statutory auditor) · General meeting decision6 facts ▸
- General meeting, 19-06-2013
- Director resignation, ENHANCED HEALTHCARE MANAGEMENT SPRL (director)
- General meeting, 20-09-2013
- Director resignation, SCRL Ernst & Young Réviseurs d'Entreprises (statutory auditor)
- Auditor appointment, KPMG Réviseurs d'Entreprises (statutory auditor)
- General meeting decision, ne pas nommer un nouvel administrateur vu que la société ne compte que deux actionnaires
17-09
State Gazette act
Resignations & appointmentsPower of attorney8 facts ▸
State Gazette act
Resignations & appointments
Power of attorney8 facts ▸
- Board meeting, 22-05-2013
- Power of attorney, Jan NOTEBOOM
- Power of attorney, Sylvie HATERT
- Power of attorney, ENHANCED HEALTHCARE MANAGEMENT SPRL
- Board meeting, 19-07-2013
- Power of attorney, Nigel MANSFORD
- Power of attorney, Jan NOTEBOOM
- Power of attorney, Sylvie HATERT
26-04
State Gazette act
Resignations: Reto Flückiger (director) and Oliver Oellers (director)Appointments: Clare Jane Bates (director) and Graham Millan Mcintosh (director) · Statutes amendment · Mandate compensation9 facts ▸
State Gazette act
Resignations: Reto Flückiger (director) and Oliver Oellers (director)
Appointments: Clare Jane Bates (director) and Graham Millan Mcintosh (director) · Statutes amendment · Mandate compensation9 facts ▸
- General meeting, 28-03-2013
- Statutes amendment
- Statutes amendment
- Director resignation, Reto Flückiger (director)
- Director resignation, Oliver Oellers (director)
- Director appointment, Clare Jane Bates (director)
- Director appointment, Graham Millan Mcintosh (director)
- Mandate compensation, Clare Jane Bates
- Mandate compensation, Graham Millan Mcintosh
2012
01-08
State Gazette act
Capital & sharesCapital increase · Bank account · Capital4 facts ▸
State Gazette act
Capital & shares
Capital increase · Bank account · Capital4 facts ▸
- General meeting, 26-06-2012
- Capital increase, €500.000
- Bank account, Deutsche Bank AG Belgium, 826-1236355-10
- Capital, €800.000
2011
07-09
State Gazette act
Appointment: ENHANCED HEALTHCARE MANAGEMENT (director)Permanent representative: Vincent Lachapelle3 facts ▸
State Gazette act
Appointment: ENHANCED HEALTHCARE MANAGEMENT (director)
Permanent representative: Vincent Lachapelle3 facts ▸
- General meeting, 01-08-2011
- Director appointment, ENHANCED HEALTHCARE MANAGEMENT (director)
- Permanent representative, Vincent Lachapelle
07-09
State Gazette act
Appointment: ENHANCED HEALTHCARE MANAGEMENT (managing director)Permanent representative: Vincent Lachapelle · Power of attorney6 facts ▸
State Gazette act
Appointment: ENHANCED HEALTHCARE MANAGEMENT (managing director)
Permanent representative: Vincent Lachapelle · Power of attorney6 facts ▸
- Board meeting, 01-08-2011
- Director appointment, ENHANCED HEALTHCARE MANAGEMENT (managing director)
- Permanent representative, Vincent Lachapelle
- Power of attorney, ENHANCED HEALTHCARE MANAGEMENT
- Power of attorney, Luc HERTEN
- Power of attorney, Sylvie HATERT
01-08
State Gazette act
Resignations: Pharadigm Management Spri (director) and Michael Lonsert (director)Appointment: Oliver Oellers (director) · Reappointment: Ernst & Young (statutory auditor)5 facts ▸
State Gazette act
Resignations: Pharadigm Management Spri (director) and Michael Lonsert (director)
Appointment: Oliver Oellers (director) · Reappointment: Ernst & Young (statutory auditor)5 facts ▸
- General meeting, 15-06-2011
- Director resignation, Pharadigm Management Spri (director)
- Director resignation, Michael Lonsert (director)
- Director appointment, Oliver Oellers (director)
- Auditor reappointment, Ernst & Young
2010
16-12
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 10-11-2010
- Registered-office move, 1300 Wavre, Avenue Pasteur 2
21-10
State Gazette act
Resignation: PHARADIGM MANAGEMENT SPRL (managing director)Power of attorney5 facts ▸
State Gazette act
Resignation: PHARADIGM MANAGEMENT SPRL (managing director)
Power of attorney5 facts ▸
- Board meeting, 10-09-2010
- Power of attorney, Jan VAN DER AUWERA
- Director resignation, PHARADIGM MANAGEMENT SPRL (managing director)
- Power of attorney, Sylvie HATERT
- Power of attorney, Luc HERTEN
02-08
State Gazette act
Permanent representative: Benoît Jean Denis QuittreCapital increase · Capital decrease · Capital8 facts ▸
State Gazette act
Permanent representative: Benoît Jean Denis Quittre
Capital increase · Capital decrease · Capital8 facts ▸
- General meeting, 03-06-2010
- Capital increase, €1.900.000
- Capital increase, €5.069.741
- Capital increase, €235.000
- Capital decrease, €9.739.741
- Capital, €300.000
- Permanent representative, Benoît Jean Denis Quittre
- Power of attorney, Benoît Jean Denis Quittre
30-06
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Power of attorney · Capital decrease11 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital increase · Power of attorney · Capital decrease11 facts ▸
- General meeting, 03-06-2010
- Capital increase, €1.900.000
- Power of attorney, Pharadigm Management Sprl
- Capital increase, €5.069.741
- Power of attorney, Pharadigm Management Sprl
- Capital increase, €235.000
- Power of attorney, Pharadigm Management Sprl
- Capital decrease, €9.739.741
- Power of attorney, Pharadigm Management Sprl
- Statutes amendment
- Auditor report, 17-05-2010
29-03
State Gazette act
Appointments: Pharadigm Management Sprl (managing director) and Jan Van der Auwera (day-to-day manager)Permanent representative: Benoit Quittre4 facts ▸
State Gazette act
Appointments: Pharadigm Management Sprl (managing director) and Jan Van der Auwera (day-to-day manager)
Permanent representative: Benoit Quittre4 facts ▸
- Board meeting, 24-02-2010
- Director appointment, Pharadigm Management Sprl (managing director)
- Permanent representative, Benoit Quittre
- Director appointment, Jan Van der Auwera (day-to-day manager)
25-03
State Gazette act
Resignation: Christian Mutzner (director)Appointment: Pharadigm Management (director) · Permanent representative: Benoit Jean Denis Quittre · Mandate compensation6 facts ▸
State Gazette act
Resignation: Christian Mutzner (director)
Appointment: Pharadigm Management (director) · Permanent representative: Benoit Jean Denis Quittre · Mandate compensation6 facts ▸
- General meeting, 24-02-2010
- Director resignation, Christian Mutzner (director)
- Director appointment, Pharadigm Management (director)
- Permanent representative, Benoit Jean Denis Quittre
- Mandate compensation, Pharadigm Management
- Name change, pharmexx
2009
16-11
State Gazette act
Resignation: Philippe VANDIEST (managing director)2 facts ▸
State Gazette act
Resignation: Philippe VANDIEST (managing director)
2 facts ▸
- Board meeting, 29-10-2009
- Director resignation, Philippe VANDIEST (managing director)
16-11
State Gazette act
Resignations: Thomas GOTZMANN, Michael SCHOMAKER and 2 othersAppointments: Reto FLÜCKIGER, Michael LONSERT and Christian MUTZNER8 facts ▸
State Gazette act
Resignations: Thomas GOTZMANN, Michael SCHOMAKER and 2 others
Appointments: Reto FLÜCKIGER, Michael LONSERT and Christian MUTZNER8 facts ▸
- General meeting, 29-10-2009
- Director resignation, Thomas GOTZMANN (director)
- Director resignation, Michael SCHOMAKER (director)
- Director resignation, Philippe VANDIEST (director)
- Director resignation, Hervé JOIE (director)
- Director appointment, Reto FLÜCKIGER (director)
- Director appointment, Michael LONSERT (director)
- Director appointment, Christian MUTZNER (director)
2007
26-02
State Gazette act
Resignations: BALARDES, VANDIEST & C° and Jehan Liénart van Lidthe de JeudeAppointments: Michael SCHOMAKER, Thomas Hubert GOTZMANN and Philippe Vandiest7 facts ▸
State Gazette act
Resignations: BALARDES, VANDIEST & C° and Jehan Liénart van Lidthe de Jeude
Appointments: Michael SCHOMAKER, Thomas Hubert GOTZMANN and Philippe Vandiest7 facts ▸
- General meeting, 23-08-2006
- Director resignation, BALARDES (director)
- Director resignation, VANDIEST & C° (director)
- Director resignation, Jehan Liénart van Lidthe de Jeude (director)
- Director appointment, Michael SCHOMAKER (chair of the board)
- Director appointment, Thomas Hubert GOTZMANN (director)
- Director appointment, Philippe Vandiest (managing director)
2004
10-12
State Gazette act
Capital & shares · Statutes amendmentCapital · Capital increase · Share issue11 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital · Capital increase · Share issue11 facts ▸
- General meeting, 19-11-2004
- Capital, €223.104,17
- Capital increase, €276.895,83
- Share issue, 111.11111, division
- Capital increase, €110.000
- Bank account, KBC BANK, Agence Coningham à Bruxelles, 734-0132065-57
- Capital, €610.000
- Statutes amendment
- Capital, €110.000
- Power of attorney, Philippe VANDIEST
- Power of attorney, Jehan LIENART van LIDTH de JEUDE
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
27 of 28 acts read
About the unread acts
Of the 28 Belgian State Gazette acts we know for this company, 27 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2021
Board 1
Benjamin RAPP
CurrentDirector · since 28-09-2021
7 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Thomas Hubert GOTZMANN
Not recently confirmedDirector · since 23-08-2006
Pharadigm Management
Not recently confirmedDirector · since 24-02-2010 · Legal entity · perm. rep.: Benoit Jean Denis Quittre
ENHANCED HEALTHCARE MANAGEMENT
Not recently confirmedDirector · since 01-08-2011 · Legal entity · perm. rep.: Vincent Lachapelle
Clare Jane Bates
Not recently confirmedDirector · since 28-03-2013
Julian Hedley Tompkins
Not recently confirmedDirector · since 20-12-2013
Jan NOTEBOOM
Not recently confirmedDirector · since 16-09-2019
Mick OLEARY
Not recently confirmedDirector · since 16-09-2019
Day-to-day management 3
Pharadigm Management
Not recently confirmedManaging director · since 24-02-2010 · Private limited company · perm. rep.: Benoit Quittre
ENHANCED HEALTHCARE MANAGEMENT
Not recently confirmedManaging director · since 01-08-2011 · Legal entity · perm. rep.: Vincent Lachapelle
Jan Van der Auwera
Not recently confirmedDay-to-day manager · since 29-03-2010
Permanent representatives 2
Benoit Quittre
Not recently confirmedPermanent representative · since 24-02-2010 · for Pharadigm Management
Vincent Lachapelle
Not recently confirmedPermanent representative · since 01-08-2011 · for ENHANCED HEALTHCARE MANAGEMENT
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
1 of this company's 28 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 1999
Ground area
5,120 m²
Building footprint
1,333 m²
Volume, LiDAR
20,806 m³
Parcel 23094D0031/00H000, Flanders · tallest building 20.5 m, ±5 floors. Linked by address, not a title deed.
11
companies at this address
See who is registered here
1 establishment unit
pharmexx
since 19992.068.095.824
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23094D0031/00H000 | Flanders | 5,120 m² | 1 · 1,333 m² | 20.4 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
32 people since 2006, 10 in office
- Board
- Day-to-day management
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Benjamin RAPP |
|
| Thomas Hubert GOTZMANN |
|
| Pharadigm Management |
|
| ENHANCED HEALTHCARE MANAGEMENT |
|
| Clare Jane Bates |
|
| Julian Hedley Tompkins |
|
| Jan NOTEBOOM |
|
| Mick OLEARY |
|
| Pharadigm Management |
|
| Jan Van der Auwera |
|
| Mick O'LEARY |
|
| Julian TOMPKINS |
|
| Nigel MANSFORD |
|
| Christophe REYNTJENS |
|
| KPMG |
|
| Clare BATES |
|
| Graham Millan Mcintosh |
|
| Ernst et Young Reviseurs d'Entreprises |
|
| ENHANCED HEALTHCARE MANAGEMENT SPRL |
|
| Oliver Oellers |
|
| Reto FLÜCKIGER |
|
| Michael LONSERT |
|
| Pharadigm Management Spri |
|
| PHARADIGM MANAGEMENT SPRL |
|
| Christian MUTZNER |
|
| Philippe Vandiest |
|
| Hervé JOIE |
|
| Michael SCHOMAKER |
|
| Thomas GOTZMANN |
|
| BALARDES |
|
| Jehan Liénart van Lidthe de Jeude |
|
| VANDIEST EN CO |
|
Articles of association
Purpose
Alle nijverheids-, handels-, financiële, roerende of onroerende activiteiten uit te oefenen die verband houden met: In- of uitvoer, aan- of verkoop, groot- of kleinhandel…
Full purpose
Alle nijverheids-, handels-, financiële, roerende of onroerende activiteiten uit te oefenen die verband houden met: In- of uitvoer, aan- of verkoop, groot- of kleinhandel, distributie, vertegenwoordiging, nationale of internationale vertegenwoordiging, financiering, huur van om het even welk product, machine of systeem, onderzoek en fabricage, promotie en marketing, alsmede diensten in verband met de gezondheid, de verzorging en het onderhoud van mensen, dieren of planten, alsmede elke betrokkenheid bij het milieu. Het organiseren van cursussen, opleidingen, studiedagen, congressen met betrekking tot voormeld object, marktonderzoek, het produceren en vervaardigen van promotiemateriaal, het organiseren van evenementen, consultancy, interim-management, het maken en introduceren van registratiedossiers van producten met betrekking tot voormeld voorwerp, koeriersdiensten, alsmede het werven, oprichten, ter beschikking stellen, huren, organiseren en coördineren van medische teams.
Structure & network
Owners and holdings
2 ownersChain of control
- Ashfield Healthcare GmbhDE
- ASHFIELD
Highest known parent: Ashfield Healthcare Gmbh (Germany). The sources do not say who stands above it.
Owners 2
- Ashfield Healthcare GmbhDEparentSourceown accounts 202599.91%
- Ashfield Direct GmbhDESourceown accounts 20250.09%
Holdings 0
The accounts to 31-12-2025 list no holdings, and no other source names one.
According to the 2025 annual accounts of ASHFIELD and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Capital and shareholders
Shareholders according to the acts
After 2 capital increases
act of 10-12-2004 ↗
- VANDIEST & C° (BE 0462.673.865) 7,500 shares
- VESALE PHARMACEUTICA 10,000 shares
- Jehan LIENART van LIDTH de JEUDE 15,000 shares
- Bernard LEVIE 27,500 shares
- Olivier Adrien Claude Marie Ghislain Pierre Comte d'URSEL 12,500 shares
- Cédric André Alix Fernand Corneille Ghislain LIENART van LIDTH de JEUDE 12,500 shares
- Cédric Lino Marie Claude Romuald Comte du MONCEAU de BERGENDAL 12,500 shares
- Cédric Marie Simon Pierre François LEVIE 12,500 shares
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 08-10-2021 Capital stated in the act · 800,000 EUR · 15,207,533 shares
- 01-08-2012 Capital increase of 500,000 EUR · to 800,000 EUR · 9,504,708 new shares · in cash
- 02-08-2010 Capital increase of 1,900,000 EUR · to 4,735,000 EUR · 1,079,248 new shares · in cash
- 02-08-2010 Capital increase of 5,069,741 EUR · to 9,804,741 EUR · 2,879,740 new shares · in kind
- 02-08-2010 Capital increase of 235,000 EUR · to 10,039,741 EUR · from reserves
- 02-08-2010 Capital reduction of 9,739,741 EUR · to 300,000 EUR · to absorb losses
- 30-06-2010 Capital increase of 1,900,000 EUR · 1,079,248 new shares · in cash
- 30-06-2010 Capital increase of 5,069,741 EUR · 2,879,740 new shares · in kind
Show 4 older capital entries
- 30-06-2010 Capital increase of 235,000 EUR · no new shares · from reserves
- 30-06-2010 Capital reduction of 9,739,741 EUR · to absorb losses
- 10-12-2004 Capital increase of 276,895.83 EUR · to 500,000 EUR · from reserves
- 10-12-2004 Capital increase of 110,000 EUR · to 610,000 EUR · 110,000 new shares
Public money · subsidies and aid
Flemish government
2022 to 2025 · 3 entries · 3,421 EUR awarded · 3,421 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 669 EUR | 669 EUR |
| 2023 | 1 | 1,133 EUR | 1,133 EUR |
| 2022 | 1 | 1,619 EUR | 1,619 EUR |
Schemes
Recognitions · licences · registrations
Legal Entity Identifier
875500GR4X6U3C4X5606
Similar companies · same sector, comparable size
IMPEXECO
BE 0477.407.472
Mouscron · Eq €2,257,511
ASP BELGIUM
BE 0691.974.442
Sint-Joost-ten-Node · Eq €2,251,098
CRETEUR ORTHOPEDIE
BE 0425.292.540
Mons · Eq €2,291,435
BRUSSELS REPS PHARMA
BE 0480.073.487
Anderlecht · Eq €2,297,185
Lansinoh Laboratories Benelux
BE 0630.939.468
Herentals · Eq €2,308,102
Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 689 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded04-08-1994
Fiscal year end31-12
Activities, NACEBEL 2025
46120Wholesale trade
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID
0208:0453211516
Also
9925:BE0453211516
Registered
09-07-2025
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.